Skip to content
★ Sign in to follow
JR

John R. Treace

Board Director
Director
Treace Medical Concepts, Inc.Wright Medical Group Inc
Total declarations
10
Companies
2
▲ Purchases (4 ops.)
€322k
▼ Sales (5 ops.)
€6.6M

Latest filing published 11 May 2022 for Treace Medical Concepts, INC., €255k.

Filing timeline

BuySale
John R. Treace

Insider track record

Disclosed buys
4
Disclosed sells
5
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

John R. Treace: trading record in brief

John R. Treace (board member) discloses dealings in 2 companies, chiefly Treace Medical Concepts, Inc. and Wright Medical Group Inc. In total, 10 filings cover trades dated from 23 February 2006 to 9 May 2022.

The open-market side counts 4 purchases for €322k alongside 5 sales for €6.6M. Taken together, the sales exceed the purchases by €6.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2022 alone, the filings show no purchases and 4 sales.

A typical purchase (the median) is worth €80k.

The newest entry dates from 11 May 2022: an open-market sale of €255k, in Treace Medical Concepts, Inc. The last purchase on record was published on 27 February 2006, which is 7,560 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to John R. Treace

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations